PL3.2 Trabectedin for recurrent WHO grade II or III meningioma: a randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
| Autor: | Preusser, M, Silvani, A, Rhun, E Le, Soffietti, R, Lombardi, G, Sepulveda, J, Brandal, P, Beaney, R, Bonneville-Levard, A, Lorgis, V, Bromberg, J, Erridge, S, Cameron, A, Marosi, C, Golfinopoulos, V, Gorlia, T, Weller, M, Wick, W |
|---|---|
| Zdroj: | Neuro-Oncology; 2019 Supplement, Vol. 21, piii2-iii3, 2p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|